China Resources Jiangzhong Pharmaceutical Co., Ltd. Class ASSE: 600750

"CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO., LTD."Announcement on Obtaining the Proprietary Chinese Medicine Registration Certificate in Macao for Jianwei Xiaoshi Tablet

Sep 11, 2026 · Issued by China Resources Jiangzhong Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Sep 11, 2026

Announcement on Obtaining the Proprietary Chinese Medicine Registration Certificate in Macao for Jianwei Xiaoshi Tablet

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from China Resources Jiangzhong Pharmaceutical Co., Ltd. Class A

"CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO., LTD."Announcement on Implementation of Dividend Distribution for the First Half of 2026Sep 3
"CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO., LTD."Announcement on the Profit Distribution Plan for the First Half of 2026Aug 22
"CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO., LTD."Announcement on Convening the 2026 Semi-annual Performance BriefingAug 19
"CHINA RESOURCES JIANGZHONG PHARMACEUTICAL CO., LTD."Announcement on Implementation of Repurchase and Cancellation of Restricted Shares under the Equity Incentive PlanJul 14

All China Resources Jiangzhong Pharmaceutical Co., Ltd. Class A news releases